了解药物和免疫细胞之间的分子桥梁
Umesh Chandra Dash1, Vinayak Nayak2, Hiten Shanker Navani3
1School of Biotechnology, Campus 11, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha 751024, India.
Pharmacology & therapeutics
|February 5, 2025
概括
了解药物与免疫细胞的相互作用对于有效治疗和尽量减少不良影响至关重要. 药物基因组学和氧化还原策略可以帮助预防药物诱导的免疫毒性,并改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 与免疫细胞的药物相互作用显著影响治疗疗效和患者安全.
- 非类固醇抗炎药物 (NSAIDs),皮质类固醇和免疫抑制剂调节免疫细胞功能和免疫反应.
- 分子机制涉及与细胞表面受体的药物相互作用,抗原呈现,以及各种免疫细胞 (T细胞,B细胞,NK细胞等) 的信号通路. ) 的情况.
研究的目的:
- 在细胞水平上审查药物和免疫细胞之间的多方面的相互作用.
- 阐明药物诱导免疫毒性的机制,包括氧化还原状态的改变和反应性氧物种 (ROS) /反应性物种 (RNS) 的产生.
- 突出了解这些相互作用对于改善治疗结果和患者保护的重要性.
主要方法:
- 科学文献的审查,重点关注药物与免疫细胞相互作用.
- 对药物对免疫细胞影响的分子机制的分析.
- 检查说明药物免疫细胞相互作用和患者结果的案例研究.
主要成果:
- 药物相互作用可以改变免疫细胞信号传递,抗原呈现和氧化还原平衡,导致免疫缺陷.
- 免疫毒性表现为过敏反应,自身免疫性疾病和细胞因子释放综合征 (CRS).
- 药物基因组学和氧化还原向策略显示出缓解免疫毒性的潜力.
结论:
- 对药物与免疫细胞相互作用的深入了解对于预防药物不良反应和提高治疗疗效至关重要.
- 评估免疫状态和使用药物基因组学是最大限度地减少免疫毒性的关键策略.
- 未来的研究应该集中在抗病毒疗法,新型免疫调节方法和具有降低毒性的先进抗毒技术上.
相关概念视频
Antigens Involved in Adaptive Immunity
444
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
444
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
Cell-surface Signaling
51.4K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.4K
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K
Cellular Membranes and Drug Transport
266
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
266
Allergic Drug Reactions
806
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
806


